Last reviewed · How we verify

NCT06942585: DAKTIK

Effects of Dynamic and Kinesiology Taping on Balance and Kinesthesia in Healthy Adults

Completed NA Last updated 23 May 2025
What this trial tests

NA trial testing Kinesiology Tape in Dynamic Tape in 24 participants. Completed in 19 May 2025.

Timeline
1 April 2025
Primary endpoint
16 May 2025
19 May 2025

Quick facts

Lead sponsorUniversity of Primorska
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposeprevention
Enrollment24
Start date1 April 2025
Primary completion16 May 2025
Estimated completion19 May 2025
Sites1 location across Slovenia

Drugs / interventions tested

Conditions studied

Sponsor

University of Primorska

Who can join

Adults 18 to 45, any sex, with Dynamic Tape or Kinesiology Taping. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the acute effects of dynamic tape (DT) and kinesiology tape (KT) on balance and kinesthesia of the lower limbs in healthy young adults. Participants will undergo assessments of static balance and knee joint position sense before and after the application of each taping condition. The study seeks to determine whether DT or KT can provide immediate improvements in postural stability and proprioceptive accuracy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Kinesiology Tape

Trials testing the same drug.

Other recruiting trials for Dynamic Tape

Currently open trials in the same condition.

Other University of Primorska trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06942585.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing